1. Home
  2. CNTA vs ASGN Comparison

CNTA vs ASGN Comparison

Compare CNTA & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • ASGN
  • Stock Information
  • Founded
  • CNTA 2020
  • ASGN 1985
  • Country
  • CNTA United Kingdom
  • ASGN United States
  • Employees
  • CNTA N/A
  • ASGN N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • ASGN Professional Services
  • Sector
  • CNTA Health Care
  • ASGN Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • ASGN Nasdaq
  • Market Cap
  • CNTA 2.3B
  • ASGN 2.3B
  • IPO Year
  • CNTA 2021
  • ASGN 1992
  • Fundamental
  • Price
  • CNTA $22.97
  • ASGN $51.25
  • Analyst Decision
  • CNTA Strong Buy
  • ASGN Hold
  • Analyst Count
  • CNTA 11
  • ASGN 6
  • Target Price
  • CNTA $30.60
  • ASGN $61.67
  • AVG Volume (30 Days)
  • CNTA 1.5M
  • ASGN 484.8K
  • Earning Date
  • CNTA 11-11-2025
  • ASGN 10-22-2025
  • Dividend Yield
  • CNTA N/A
  • ASGN N/A
  • EPS Growth
  • CNTA N/A
  • ASGN N/A
  • EPS
  • CNTA N/A
  • ASGN 3.15
  • Revenue
  • CNTA $15,000,000.00
  • ASGN $4,004,900,000.00
  • Revenue This Year
  • CNTA N/A
  • ASGN N/A
  • Revenue Next Year
  • CNTA N/A
  • ASGN $2.42
  • P/E Ratio
  • CNTA N/A
  • ASGN $16.19
  • Revenue Growth
  • CNTA 118.88
  • ASGN N/A
  • 52 Week Low
  • CNTA $9.60
  • ASGN $46.64
  • 52 Week High
  • CNTA $23.24
  • ASGN $101.66
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 71.96
  • ASGN 47.78
  • Support Level
  • CNTA $20.94
  • ASGN $49.21
  • Resistance Level
  • CNTA $23.24
  • ASGN $51.81
  • Average True Range (ATR)
  • CNTA 1.39
  • ASGN 1.75
  • MACD
  • CNTA 0.41
  • ASGN -0.33
  • Stochastic Oscillator
  • CNTA 96.72
  • ASGN 35.92

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: